Anti-Integrin beta 5 antibody [EPR19170]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal Integrin beta 5 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 11 publications.
View Alternative Names
Integrin beta-5, ITGB5
- WB
Supplier Data
Western blot - Anti-Integrin beta 5 antibody [EPR19170] (AB184312)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 : 15 seconds; Lane 2 : 3 minutes; Lane 3 : 1 minute; Lane 4 : 3 minutes.
All lanes:
Western blot - Anti-Integrin beta 5 antibody [EPR19170] (ab184312) at 1/1000 dilution
Lane 1:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Rat lung lysate at 20 µg
Lane 3:
Neuro-2a (Mouse neuroblastoma cell line) whole cell lysate at 20 µg
Lane 4:
Mouse lung lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 88 kDa
Observed band size: 90 kDa
false
- WB
Supplier Data
Western blot - Anti-Integrin beta 5 antibody [EPR19170] (AB184312)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1, 2 and 3 : 15 seconds; Lane 4 : 1 minute
All lanes:
Western blot - Anti-Integrin beta 5 antibody [EPR19170] (ab184312) at 1/1000 dilution
Lane 1:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Lane 4:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 88 kDa
Observed band size: 90 kDa
false
Related conjugates and formulations (1)
-
Anti-Integrin beta 5 antibody [EPR19170] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Integrin beta 5 contributes to processes like cell migration proliferation and survival often occurring at cell surfaces. It is a part of the integrin complex which plays an important role in these cellular behaviors. Through its interaction with ECM proteins integrin beta 5 influences key biological activities and assists in maintaining tissue architecture. The activity of this integrin impacts how cells respond to their microenvironment influencing cellular fate decisions that are vital to growth and repair mechanisms.
Pathways
Several signaling pathways involve integrin beta 5. It actively participates in the MAPK/ERK and PI3K/AKT pathways which are essential for transmitting signals that promote cell proliferation and survival. Additionally this integrin works closely with other proteins such as focal adhesion kinase (FAK) and Src family kinases integrating signals that modulate cellular responses to mechanical and biochemical cues from the ECM.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Biology direct 20:52 PubMed40234961
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 30: PubMed39155876
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:14273 PubMed38902362
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastroenterology and hepatology 38:1158-1169 PubMed36878870
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:887068 PubMed36249018
2022
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9:e2200546 PubMed35901491
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:649862 PubMed34150753
2021
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:161 PubMed33547385
2021
Applications
Unspecified application
Species
Unspecified reactive species
Life sciences 267:118928 PubMed33358902
2020
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 20:36 PubMed32024510
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com